Lenacapavir bulk supplier for pharma manufacturers

Lenacapavir 300 mg, 463.5 mg/1.5 mL Suppliers & Bulk Manufacturers

Available Forms: Tablet / Injection

Available Strengths: 300 mg, 463.5 mg/1.5 mL

Reference Brands: Yeztugo (USA), Sunlenca (USA)

Lenacapavir is a Anti Viral product available as Tablet / Injection in strengths 300 mg, 463.5 mg/1.5 mL. It corresponds to the reference brands Yeztugo (USA), Sunlenca (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Lenacapavir? List it or send an offer →

Product Description:

Lenacapavir is a long-acting antiretroviral medication used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection, particularly in heavily treatment-experienced patients with multidrug-resistant virus where existing therapies are no longer effective or tolerated. It belongs to a novel class of medicines known as HIV-1 capsid inhibitors and works by targeting the viral capsid protein, disrupting multiple stages of the viral life cycle including assembly, transport, and replication. This unique mechanism makes it effective against strains resistant to other antiretroviral classes.

Lenacapavir is used in combination with other antiretroviral agents as part of an optimized background regimen. One of its key advantages is its long-acting profile, allowing extended dosing intervals that can improve adherence and treatment continuity. Clinical studies have shown strong antiviral activity, sustained viral load reduction, and a manageable safety profile in patients with limited treatment options. It is marketed under the brand name Sunlenca and developed by Gilead Sciences. Ongoing research is also exploring its role in long-acting preventive strategies and combination regimens for durable HIV management.

Lenacapavir — third party manufacturing & bulk supply

Lenacapavir 300 mg, 463.5 mg/1.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lenacapavir is supplied as Tablet / Injection — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lenacapavir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lenacapavir →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing